Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled "Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 09, 2023, titled "Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension".